S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
S&P 500   4,443.11
DOW   34,869.37
QQQ   370.35
OTCMKTS:VBIO

Vitality Biopharma Short Interest Ratio and Short Volume

$0.24
-0.09 (-27.27 %)
(As of 09/27/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.24
$0.36
50-Day Range
$0.19
$0.80
52-Week Range
$0.05
$0.85
Volume399,637 shs
Average Volume77,568 shs
Market Capitalization$12.29 million
P/E RatioN/A
Dividend YieldN/A
Beta3.83

Vitality Biopharma (OTCMKTS:VBIO) Short Interest Data

Current Short Volume11,500 shares
Previous Short Volume100 shares
Change Vs. Previous Month+11,400.00%
Dollar Volume Sold Short$7,015.00
Short Interest Ratio / Days to Cover0.1
Last Record DateAugust, 31 2021
Outstanding Shares51,200,000 shares
Percentage of Shares Shorted0.02%
Today's Trading Volume399,637 shares
Average Trading Volume77,568 shares
Today's Volume Vs. Average415.21%

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Vitality Biopharma ?

Sign up to receive the latest short interest report for Vitality Biopharma and its competitors with MarketBeat's FREE newsletter.

Vitality Biopharma (OTCMKTS:VBIO) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202111,500 shares $7,015.00 +11,400.0%N/A0.1 $0.61
8/13/2021100 shares $27.74 No ChangeN/A0 $0.28
7/15/202125,000 shares $4,867.50 +987.0%N/A0.1 $0.19
6/30/20212,300 shares $480.70 +2,200.0%N/A0 $0.21
6/15/2021100 shares $16.50 No ChangeN/A0 $0.17
5/14/2021600 shares $102.00 No ChangeN/A0 $0.17
4/15/20214,800 shares $868.80 No ChangeN/A0.1 $0.18
3/15/20211,800 shares $378.00 +260.0%N/A0 $0.21
2/26/2021500 shares $82.50 No ChangeN/A0 $0.17
2/12/2021500 shares $150.00 No ChangeN/A0 $0.30
1/29/2021500 shares $40.00 -92.1%N/A0 $0.08
1/15/20212,300 shares $144.90 +360.0%N/A0.1 $0.06
12/31/2020500 shares $40.00 -78.3%N/A0 $0.08
12/15/20202,300 shares $230.00 +360.0%N/A0.1 $0.10
11/30/2020500 shares $70.00 No ChangeN/A0 $0.14
10/30/2020500 shares $80.00 No ChangeN/A0 $0.16
10/15/2020500 shares $75.00 No ChangeN/A0 $0.15
9/30/2020500 shares $85.00 No ChangeN/A0 $0.17
9/15/2020500 shares $100.00 No ChangeN/A0 $0.20
8/31/2020500 shares $110.00 No ChangeN/A0 $0.22
8/14/2020500 shares $100.00 No ChangeN/A0 $0.20
7/31/2020500 shares $79.95 No ChangeN/A0 $0.16
7/15/2020500 shares $60.00 -50.0%N/A0 $0.12
6/30/20201,000 shares $61.00 -89.0%N/A0 $0.06
6/15/20209,100 shares $455.00 +1,720.0%N/A0.2 $0.05

Vitality Biopharma (OTCMKTS:VBIO) Short Interest FAQ

speech bubbles
speech bubbles











Vitality Biopharma (OTCMKTS:VBIO) Short Interest Frequently Asked Questions

What is Vitality Biopharma's current short interest?

Short interest is the volume of Vitality Biopharma shares that have been sold short but have not yet been covered or closed out. As of August 31st, traders have sold 11,500 shares of VBIO short. Learn More on Vitality Biopharma's current short interest.

Is Vitality Biopharma's short interest increasing or decreasing?

Vitality Biopharma saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 11,500 shares, an increase of 11,400.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Vitality Biopharma's short interest compare to its competitors?

0.00% of Vitality Biopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "commercial physical research" compare to Vitality Biopharma: IQVIA Holdings Inc. (1.59%), Charles River Laboratories International, Inc. (1.22%), Bitcoin Group SE (0.00%), PPD, Inc. (13.02%), Exact Sciences Co. (0.00%), Incyte Co. (2.72%), ICON Public Limited (0.00%), Syneos Health, Inc. (2.38%), Medpace Holdings, Inc. (2.53%), and Anavex Life Sciences Corp. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short Vitality Biopharma stock?

Short selling VBIO is an investing strategy that aims to generate trading profit from Vitality Biopharma as its price is falling. Vitality Biopharma's stock is trading down $0.09 today. To short Vitality Biopharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Vitality Biopharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vitality Biopharma?

A short squeeze for Vitality Biopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VBIO, which in turn drives the price of the stock up even further.

How often is Vitality Biopharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VBIO, twice per month. The most recent reporting period available is August, 31 2021.



This page was last updated on 9/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.